UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 578

Sortiert nach

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

The Lancet (British edition), 2020-05, Vol.395 (10237), p.1613-1626

2020

Link zum Volltext

Verfügbarkeit prüfen

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

The lancet oncology, 2016-08, Vol.17 (8), p.1047-1060

2016

Link zum Volltext

Verfügbarkeit prüfen

One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

Health technology assessment (Winchester, England), 2023-11, Vol.27 (25), p.1-176

2023

Link zum Volltext

Verfügbarkeit prüfen

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

The lancet oncology, 2017-07, Vol.18 (7), p.929-945

2017

Link zum Volltext

Verfügbarkeit prüfen

Narrowing the gap: the effects of an expressive writing intervention on perceptions of actual and ideal emotional support in women who have completed treatment for early stage breast cancer

Psycho-oncology (Chichester, England), 2010-01, Vol.19 (1), p.77-84

2010

Link zum Volltext

Verfügbarkeit prüfen

American public education law: Primer

Bloomfield, David C

2007

Link zum Volltext

Verfügbarkeit prüfen

Pelvic radiculopathies, lumbosacral plexopathies, and neuropathies in oncologic disease: a multidisciplinary approach to a diagnostic challenge

Cancer imaging, 2013-12, Vol.13 (4), p.591-601

2013

Link zum Volltext

Verfügbarkeit prüfen

Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study

BJU international, 2005-07, Vol.96 (1), p.48-53

2005

Link zum Volltext

Verfügbarkeit prüfen

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

The Lancet (British edition), 2022-01, Vol.399 (10323), p.447-460

2022

Link zum Volltext

Verfügbarkeit prüfen

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer

Journal of clinical oncology, 2020-10, Vol.38 (28), p.3261-3272

2020

Link zum Volltext

Verfügbarkeit prüfen

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

The Lancet (British edition), 2019-06, Vol.393 (10191), p.2599-2612

2019

Link zum Volltext

Verfügbarkeit prüfen

Enhancing decision‐making about adjuvant chemotherapy in early breast cancer following EndoPredict testing

Psycho-oncology (Chichester, England), 2018-04, Vol.27 (4), p.1264-1269

2018

Link zum Volltext

Verfügbarkeit prüfen

Breast-Cancer Adjuvant Therapy with Zoledronic Acid

The New England journal of medicine, 2011-10, Vol.365 (15), p.1396-1405

2011

Link zum Volltext

Verfügbarkeit prüfen

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015)

Radiotherapy and oncology, 2011-07, Vol.100 (1), p.93-100

2011

Link zum Volltext

Verfügbarkeit prüfen

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

Journal of clinical oncology, 2022-08, Vol.40 (22), p.2468-2478

2022

Link zum Volltext

Verfügbarkeit prüfen

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

The lancet oncology, 2023-05, Vol.24 (5), p.443-456

2023

Link zum Volltext

Verfügbarkeit prüfen

Patients’ views and experiences on the supported self-management/patient-initiated follow up pathway for breast cancer

Supportive care in cancer, 2023-12, Vol.31 (11), p.658-658, Article 658

2023

Link zum Volltext

Verfügbarkeit prüfen

The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial

International journal of radiation oncology, biology, physics, 2018-04, Vol.100 (5), p.1179-1189

2018

Link zum Volltext

Verfügbarkeit prüfen

A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer

JNCI : Journal of the National Cancer Institute, 2015-10, Vol.107 (10), p.djv197

2015

Link zum Volltext

Verfügbarkeit prüfen

Large breast size as a risk factor for late adverse effects of breast radiotherapy: Is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?

Radiotherapy and oncology, 2011-08, Vol.100 (2), p.236-240

2011

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer patients' perception of intra-operative radiotherapy (IORT): The South East England experience

European journal of surgical oncology, 2016-11, Vol.42 (11), p.S225-S225

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 578

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(487)
Mit Volltextzugriff
(521)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(370)
Life Sciences & Biomedicine
(308)
Humans
(264)
Male
(158)
Female
(153)
Middle Aged
(122)
Adult
(107)
Aged
(97)
Biological And Medical Sciences
(95)
Medical Sciences
(89)
Oncology
(69)
Treatment Outcome
(58)
Risk Factors
(41)
General & Internal Medicine
(40)
Physical Sciences
(38)
Adolescent
(37)
Aged, 80 And Over
(35)
Animals
(35)
Hematologic And Hematopoietic Diseases
(32)
Hematology
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(24)
Journal Of Clinical Oncology
(16)
The New England Journal Of Medicine
(15)
Cancer
(10)
The Astrophysical Journal
(10)
Journal Of The American College Of Cardiology
(9)
Plos One
(8)
The Lancet Oncology
(8)
Critical Care Medicine
(7)
Global Heart
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial

One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

Narrowing the gap: the effects of an expressive writing intervention on perceptions of actual and ideal emotional support in women who have completed treatment for early stage breast cancer

American public education law: Primer

Pelvic radiculopathies, lumbosacral plexopathies, and neuropathies in oncologic disease: a multidisciplinary approach to a diagnostic challenge

Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Enhancing decision‐making about adjuvant chemotherapy in early breast cancer following EndoPredict testing

Breast-Cancer Adjuvant Therapy with Zoledronic Acid

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015)

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

Patients’ views and experiences on the supported self-management/patient-initiated follow up pathway for breast cancer

The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial

A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer

Large breast size as a risk factor for late adverse effects of breast radiotherapy: Is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?

Breast cancer patients' perception of intra-operative radiotherapy (IORT): The South East England experience

Suchergebnisse filtern